Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients



Rating:

Share or cite this content

Citations should be made in the following way:
A. Charloux (Strasbourg, France). Who should treat lung cancer patients and where should they be treated?. Annual Congress 2009 - Fitness for radical therapy in lung cancer patients

Member's Comments

No comment yet.

Related content which might interest you: How do lung cancer patients die? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 How to treat lung cancer in IPF patients Source: Research Seminar 2015 Year: 2015 Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening? Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018 Year: 2018 Stage I lung cancer patients with or without symptoms – are the patients any different? Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 VATS in lung cancer treatment: for which patients? Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases Year: 2014 Why can initial treatment of localised lung cancer fail? Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Mianserin therapy in advanced lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002 Follow up of surgically treated non small cell lung cancer patients: which modalities? Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment Year: 2008 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Poor performance status patient in advanced lung cancer: to treat or not to treat? Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat? Year: 2008 What is real prevalence of COPD in patients with lung cancer? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Some characteristics of patients with lung cancer elected for palliative treatment Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Eosinophilia in lung cancer patients treated with immunotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Atezolizumab in previously treated non-small-cell lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006 Surgical treatment of locally recurrent lung cancer Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Dealys in the diagnosis and treatment of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004